VentriPoint Diagnostics Ltd. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was CAD 0.003891 million. Net loss was CAD 1.12 million compared to CAD 1.35 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.
For the six months, sales was CAD 0.007781 million compared to CAD 0.0246 million a year ago. Net loss was CAD 2.46 million compared to CAD 2.36 million a year ago. Basic loss per share from continuing operations was CAD 0.02 compared to CAD 0.02 a year ago.